Presentation EuroPCR 2017 Efficacy and Safety of LAA Closure with WATCHMAN in Patients with or without Contraindication to Oral Anticoagulation: 1-year FU of the EWOLUTION trial Presenter: Lucas Boersma, Martin W. Bergmann May 18, 2017
Presentation Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure Presenter: Vivek Y. Reddy December 13, 2015